Skip to content
Menu

Aura Biosciences Q3 EPS $(0.29) Beats $(0.37) Estimate

Benzinga Newsdesk 1 week ago

NewsEarningsEarnings Beats

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.37) by 21.62 percent. This is a 27.5 percent increase over losses of $(0.40) per share from

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.37) by 21.62 percent. This is a 27.5 percent increase over losses of $(0.40) per share from the same period last year.

Read at benzinga.com